By Vivien Marx
CAMBRIDGE, Mass. — Cancer is a notoriously complex disease, but molecular methods and new approaches such as network modeling are helping to tease apart the mechanisms of the disease, according to speakers at a conference held here this week
At the Network Biology 2.0 conference, speakers underscored the degree to which the understanding of cancer is being empowered by molecular characterization projects and is accompanied by desire to select the right populations for clinical trials.